Verifying Death Reports in the Platelet Inhibition and Patient Outcomes (PLATO) Trial-Reference-Cited by-同舟云学术

Verifying Death Reports in the Platelet Inhibition and Patient Outcomes (PLATO) Trial

Published:2020-10-23 Issue:6 Volume:27 Page:e563-e572
ISSN:1075-2765
Container-title:American Journal of Therapeutics
language:en
Short-container-title:

Author:

Serebruany Victor,Tanguay Jean-Francois,Benavides Mario Alberto,Cabrera-Fuentes Hector,Eisert Wolfgang,Kim Moo Hyun,Yoon Junghan,Lee Cheol-Whan,Jang Kiyuk,Swan James,Marciniak Thomas,

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology,General Medicine

Reference18 articles.

1. Mortality after oral platelet P2Y12 inhibitors in the food and drug administration adverse event reporting system;Serebruany;Am J Med.,2017

2. ESC/EACTS Guidelines on myocardial revascularization;Neumann;Eur Heart J.,2019

3. 2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology focused update of the guidelines for the use of antiplatelet therapy;Mehta;Can J Cardiol.,2018

4. ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease;Levine;JACC,2016

5. Ticagrelor versus clopidogrel in patients with acute coronary syndromes;Wallentin;N Engl J Med.,2009

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Time Course of Death After Acute Coronary Syndrome Treated With Dual Antiplatelet Therapy for 1 Year;The American Journal of Medicine;2023-05

2. Strokes and Transient Ischemic Attacks Occurrence During Annual Dual Antiplatelet Therapy;American Journal of Therapeutics;2023-03-29

3. Primary Causes of Death Reported to the FDA Suggest Less Ticagrelor Mortality Benefit than the List Issued to the PLATO Trial Investigators;Reviews in Cardiovascular Medicine;2022-04-08

4. Infections Deaths in the PLATO Trial;TH Open;2021-10

5. Misreported Cancer Deaths in PLATO Trial;Journal of Clinical Medicine;2021-07-16